Skip to content

CALM Pregnancy: results of a pilot study of mindfulness-based cognitive therapy for perinatal anxiety.

Janice H Goodman, Anthony Guarino, Kerry Chenausky, Lauri Klein, Joanna Prager, Rebecca Petersen, Avery Forget, Marlene P. Freeman

Archives of women's mental health January 22, 2014 DOI: 10.1007/s00737-013-0402-7 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Open treatment trial (pilot feasibility study) Randomized Pilot study Qualitative Peer reviewed
Sample size 24
Population Pregnant women with generalized anxiety disorder or prominent symptoms of generalized anxiety
Intervention Coping with Anxiety through Living Mindfully (CALM) Pregnancy
Topics Anxiety Depression Meditation
Keywords Humans Perinatal care Feasibility studies Pilot projects Adaptation, psychological Pregnancy Adult Middle aged Female Surveys and questionnaires Cognitive behavioral therapy
Key findings In an open trial, 23 of 24 pregnant women with anxiety completed the CALM Pregnancy mindfulness-based intervention, and completers showed statistically and clinically significant improvements in anxiety, worry, and depression plus increases in self-compassion and mindfulness. Of 17 who met GAD criteria at baseline, only one still met criteria post-intervention. The authors argue the intervention holds potential as effective non-pharmacological treatment and warrants a randomized controlled trial.

Abstract

Many women experience anxiety during pregnancy with potential negative effects on maternal, birth, and child outcomes. Because of potential risks of fetal exposure to psychotropic medications, efficacious non-pharmacologic approaches are urgently needed. However, no published studies of psychotherapeutic treatments for anxiety in pregnancy exist. Mindfulness-based cognitive therapy (MBCT) may substantially reduce anxiety and co-morbid symptoms in people with anxiety disorders. Coping with Anxiety through Living Mindfully (CALM) Pregnancy is an adaptation of MBCT designed to address anxiety in pregnant women. This study examined the feasibility, acceptability, and clinical outcomes of the CALM Pregnancy intervention in pregnant women anxiety. Twenty-four pregnant women with generalized anxiety disorder (GAD) or prominent symptoms of generalized anxiety participated in an open treatment trial of the CALM Pregnancy group intervention. Psychiatric diagnoses were determined by structured clinical interview, and self-report measures of anxiety, worry, depression, self-compassion, and mindfulness were completed at baseline and post-intervention. Qualitative feedback was elicited via questionnaire. Twenty-three participants completed the intervention with high attendance and good compliance with home practice. Completers showed statistically and clinically significant improvements in anxiety, worry, and depression, and significant increases in self-compassion and mindfulness. Of the 17 participants who met GAD criteria at baseline, only one continued to meet criteria post-intervention. Participants regarded their experience in the intervention to be overwhelmingly positive. MBCT in the form of the CALM Pregnancy intervention holds potential to provide effective, non-pharmacological treatment for pregnant women with anxiety. These promising findings warrant further testing of the intervention with a randomized controlled trial.

Comparable studies

Other non-randomized and open-label trials on anxiety, most cited first.

Study Year Design Participants
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression Patients with treatment-resistant depression 2018 Clinical trial n = 20
Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder Subjects with obsessive-compulsive disorder (OCD) 2006 Controlled clinical trial
Rapid Resolution of Suicidal Ideation After a Single Infusion of anN-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder Subjects with DSM-IV-diagnosed treatment-resistant major depressive disorder 2010 Open-label trial n = 33
Emotions and brain function are altered up to one month after a single high dose of psilocybin. Healthy volunteers (7 female, 5 male) 2020 Open-label pilot study n = 12
Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study Older long-term AIDS survivor (OLTAS) self-identified gay men with moderate-to-severe... 2020 Open-label study

Citations in the library

Cited by 34

and 29 more in the library

Cites 24

and 19 more in the library

Explore topics